![Schematic drawing illustrating the potential mechanism of action of... | Download Scientific Diagram Schematic drawing illustrating the potential mechanism of action of... | Download Scientific Diagram](https://www.researchgate.net/profile/Beata-Sperlagh/publication/290478818/figure/fig7/AS:318362757419017@1452915004533/Schematic-drawing-illustrating-the-potential-mechanism-of-action-of-novel_Q640.jpg)
Schematic drawing illustrating the potential mechanism of action of... | Download Scientific Diagram
![Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update - Tripathi - 2019 - Medicinal Research Reviews - Wiley Online Library Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update - Tripathi - 2019 - Medicinal Research Reviews - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0f59f1af-7bc3-44d4-a067-09350ac39cb5/med21561-fig-0003-m.png)
Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update - Tripathi - 2019 - Medicinal Research Reviews - Wiley Online Library
![Safinamide as Add-on Therapy – Moving Beyond Dopamine for a Multifaceted Approach in Parkinson's Disease - touchNEUROLOGY Safinamide as Add-on Therapy – Moving Beyond Dopamine for a Multifaceted Approach in Parkinson's Disease - touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2017/10/Figure_1_Dopaminergic_action_of_safinamide.png)
Safinamide as Add-on Therapy – Moving Beyond Dopamine for a Multifaceted Approach in Parkinson's Disease - touchNEUROLOGY
![Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease | Semantic Scholar Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9b3de25de2862ffe4183b6ad24f1f34677ba6098/3-Figure1-1.png)
Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease | Semantic Scholar
![Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease | Semantic Scholar Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9b3de25de2862ffe4183b6ad24f1f34677ba6098/6-Figure2-1.png)
Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease | Semantic Scholar
![Physiological functions of MAO and types of MAO inhibitors with their... | Download Scientific Diagram Physiological functions of MAO and types of MAO inhibitors with their... | Download Scientific Diagram](https://www.researchgate.net/profile/Amit-Kumar-Srivastava-2/publication/279306450/figure/fig2/AS:512259589324800@1499143611671/Physiological-functions-of-MAO-and-types-of-MAO-inhibitors-with-their-drawbacks-and.png)
Physiological functions of MAO and types of MAO inhibitors with their... | Download Scientific Diagram
![An interesting commentary on the interpretation of the Nilotinib trial results – The Science of Parkinson's An interesting commentary on the interpretation of the Nilotinib trial results – The Science of Parkinson's](https://scienceofpd.files.wordpress.com/2017/01/maoi-inhibitor.png)
An interesting commentary on the interpretation of the Nilotinib trial results – The Science of Parkinson's
![Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease | Translational Neurodegeneration | Full Text Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease | Translational Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2047-9158-2-19/MediaObjects/40035_2013_Article_44_Fig1_HTML.jpg)
Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease | Translational Neurodegeneration | Full Text
![Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease | SpringerLink Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-018-1952-7/MediaObjects/702_2018_1952_Fig1_HTML.png)
Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease | SpringerLink
![Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis | Experimental & Molecular Medicine Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis | Experimental & Molecular Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs12276-021-00646-3/MediaObjects/12276_2021_646_Fig5_HTML.png)